About Glucose-6-phosphatase catalytic subunit 1
Glucose-6-phosphatase catalytic subunit 1 (G6PC1) is a protein
from Homo sapiens identified by UniProt accession
P35575, 357 residues long.
MolForge cross-references it against 0 known binders and
293 disease associations.
Target properties
| Protein name | Glucose-6-phosphatase catalytic subunit 1 |
| UniProt accession | P35575 |
| Gene | G6PC1 |
| Organism | Homo sapiens |
| Length | 357 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (293)
Diseases linked to this target (Open Targets).
- glycogen storage disease due to glucose-6-phosphatase deficiency type IA · score 0.81
- Glycogen storage disease due to glucose-6-phosphatase deficiency · score 0.74
- Glycogen storage disease due to glucose-6-phosphatase deficiency type a · score 0.70
- disorder of glycogen metabolism · score 0.58
- glycogen storage disease I · score 0.48
- genetic disorder · score 0.41
- Hypoglycemia · score 0.35
- Short stature · score 0.34
- creatinine measurement · score 0.34
- triglyceride measurement · score 0.29
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P35575-F1 | alphafold | PREDICTED | 92.21 | — |
Amino-acid sequence (357 residues)
MEEGMNVLHD FGIQSTHYLQ VNYQDSQDWF ILVSVIADLR NAFYVLFPIW FHLQEAVGIK LLWVAVIGDW LNLVFKWILF GQRPYWWVLD TDYYSNTSVP LIKQFPVTCE TGPGSPSGHA MGTAGVYYVM VTSTLSIFQG KIKPTYRFRC LNVILWLGFW AVQLNVCLSR IYLAAHFPHQ VVAGVLSGIA VAETFSHIHS IYNASLKKYF LITFFLFSFA IGFYLLLKGL GVDLLWTLEK AQRWCEQPEW VHIDTTPFAS LLKNLGTLFG LGLALNSSMY RESCKGKLSK WLPFRLSSIV ASLVLLHVFD SLKPPSQVEL VFYVLSFCKS AVVPLASVSV IPYCLAQVLG QPHKKSL
Explore Glucose-6-phosphatase catalytic subunit 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets